Neuralink Enrolls 21 Trial Participants in Human Implant Study
Elon Musk's brain-computer interface company has now implanted 21 people with its neural device, marking a significant acceleration in its clinical trial timeline.
Elon Musk's brain-computer interface company has now implanted 21 people with its neural device, marking a significant acceleration in its clinical trial timeline.
Researchers demonstrate that individualized fMRI models can decode spontaneous pain in chronic pain patients, marking a shift toward objective, brain-based pain measurement that could reshape treatment and neurotech interventions.
The cryptocurrency giant's massive investment in one of the oldest BCI companies signals an unexpected collision between digital currency and neurotechnology sectors.
Cortical Labs demonstrated human brain cells on a chip mastering basic gameplay within seven days, advancing the case for biological computing in real-world applications.
Brazilian neuroscientist Miguel Nicolelis leads research with Chinese collaborators demonstrating that brain-computer interface technology can trigger neural reorganization and restore movement in paralyzed patients.
Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.